Upload File

The top documents tagged [cross cancer institute]

Leap Winter 2012
Leap Winter 2012
418 views
astro 2006
astro 2006
120 views
Clinical Nutrition Week 2014 (CNW14)
Clinical Nutrition Week 2014 (CNW14)
131 views
Clinical Nutrition Week 2014 (CNW14)
Clinical Nutrition Week 2014 (CNW14)
164 views
Structure and function of a lipid bilayer membrane and its integral membrane proteins Acknowledgment J.A. Tuszynski, M. Duszyk, R.N. McElhaney, O.S. Andersen
Structure and function of a lipid bilayer membrane and its integral membrane proteins Acknowledgment J.A. Tuszynski, M. Duszyk, R.N. McElhaney, O.S. Andersen
215 views
A Classification-based Glioma Diffusion Model Using MRI Data Marianne Morris 1,2 Russ Greiner 1,2, Jörg Sander 2, Albert Murtha 3, Mark Schmidt 1,2 1 Alberta
A Classification-based Glioma Diffusion Model Using MRI Data Marianne Morris 1,2 Russ Greiner 1,2, Jörg Sander 2, Albert Murtha 3, Mark Schmidt 1,2 1 Alberta
215 views
Sponsorship Proposal We are proud to be Canada's only national foundation dedicated to raising awareness, advancing pancreatic
Sponsorship Proposal We are proud to be Canada's only national foundation dedicated to raising awareness, advancing pancreatic
214 views
Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 / NO16966, a randomized phase III trial in first-line metastatic
Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 / NO16966, a randomized phase III trial in first-line metastatic
226 views
Maintenance of physical activity in breast cancer survivors after a randomized trial J Vallance 1, KS Courneya 2, RC Plotnikoff 3, I Dinu 3, & JR Mackey
Maintenance of physical activity in breast cancer survivors after a randomized trial J Vallance 1, KS Courneya 2, RC Plotnikoff 3, I Dinu 3, & JR Mackey
213 views
XELOX-1/NO16966, a randomized phase III trial of first-line XELOX vs. FOLFOX-4 for patients with metastatic colorectal cancer (MCRC): Updated overall survival
XELOX-1/NO16966, a randomized phase III trial of first-line XELOX vs. FOLFOX-4 for patients with metastatic colorectal cancer (MCRC): Updated overall survival
221 views
Cachexia = Y … … 5.690.340.8316.018.442.73599.3314.2 Leucine Lactos e Lactate Isopropan ol Isoleucin e Histidin e Hippurat e Glucose CYCY CNCN Using Metabolomic
Cachexia = Y … … 5.690.340.8316.018.442.73599.3314.2 Leucine Lactos e Lactate Isopropan ol Isoleucin e Histidin e Hippurat e Glucose CYCY CNCN Using Metabolomic
216 views
XELOX vs. FOLFOX4: survival and response results from XELOX-1 / NO16966, a randomized phase III trial of first-line treatment for patients with metastatic
XELOX vs. FOLFOX4: survival and response results from XELOX-1 / NO16966, a randomized phase III trial of first-line treatment for patients with metastatic
214 views